Acarix AB (publ) (STO: ACARIX)

Market Cap	339.30M
Revenue (ttm)	5.68M
Net Income (ttm)	-72.23M
Shares Out	1.06B
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,093,582
Open	0.318
Previous Close	0.320
Day's Range	0.315 - 0.330
52-Week Range	0.175 - 0.599
Beta	1.39
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 14
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX

Financial Performance

In 2023, Acarix AB's revenue was 6.24 million, an increase of 7.20% compared to the previous year's 5.82 million. Losses were -77.84 million, 1.11% more than in 2022.